Background and aims: Granulomas are a characteristic microscopic finding in Crohn's disease. Their clinical significance is controversial and their pathogenesis is unknown, but impaired processing of bacterial components has been suggested. Autophagy is a fundamental process involved in the elimination of intracellular bacteria. Genetic variants in autophagy genes IRGM and ATG16L1 have been associated with susceptibility to Crohn's disease. We therefore investigated whether variants in autophagy genes contribute to granuloma formation. Methods: Surgical specimens from 464 clinically well-documented Crohn's patients were reviewed and scored for the presence and distribution of granulomas. All patients were genotyped for the CD-associated SNPs in ATG16L1 and IRGM as well as for 77 haplotype tagging SNPs in 13 additional autophagy genes. Results: Granulomas were found in 75% of the patients. Their frequency increased with more distal involvement of the GI tract. Granuloma positive patients were significantly younger at the time of diagnosis and surgery, and were more likely to smoke. We identified associations between granulomas and autophagy gene variants ATG4A (rs5973822), FNBP1L (rs17109951) and ATG4D (rs7248026; rs2304165; rs10439163). Conclusion: These findings suggest that granuloma formation is a marker of a more aggressive disease course, and that variants in autophagy genes ATG4A, ATG2A, FNBP1L and ATG4D, may contribute to granuloma formation.
Introduction
Crohn's disease (CD) is characterized by discontinuous chronic inflammation of the gut that can involve any segment of the gastrointestinal tract from the mouth to the anus. CD is presumed to result from a dysregulated immune response to the host's microbiota in a genetically susceptible individual. The inflammatory process in CD is transmural involving all layers of the bowel wall with epithelioid granuloma as a characteristic histopathological finding. Although granulomas are considered an important feature in CD, they are found in only 45-70% of surgical samples of CD patients. Thus, a significant proportion of CD patients do not develop granulomas. [1] [2] [3] Frequency of granulomas is not only variable between patients, but it also varies in a single patient with a higher frequency reported in the distal part of the colon. 1, 4 The absence of granulomas in a proportion of CD patients raised the possibility that these structures are markers of a particular clinical subphenotype. Indeed, some reports indicate that granulomas are more prevalent in young patients with a short disease duration. They have also been associated with a more aggressive disease course and a higher rate of postoperative recurrence. 2, [5] [6] [7] However, these findings are controversial, with opposite conclusions being reached in other studies. 3, 4, 8 Furthermore, although granuloma formation is a characteristic finding in Crohn's disease, the reason for granuloma formation is still unknown. DNA from various microorganisms, such as Mycobacterium avium subspecies paratuberculosis and Escherichia coli has been detected in granulomas of CD patients, but these findings were not conclusively replicated and may represent nothing more than a bystander phenomenon. [9] [10] [11] In the last decade, numerous genetic studies have highlighted the role of innate immunity in CD pathogenesis. The disease is strongly associated with particular variants of the NOD2/CARD15 gene in western populations. 12, 13 The protein product of this gene functions as a pattern recognition receptor binding the bacterial wall component muramyl-dipeptide, which leads to nuclear factor kB pathway activation. It has been conceived that impaired recognition of bacterial components by the innate immune system could result in granuloma formation. However, no significant association between variants of NOD2/CARD15 or TLR4 and granuloma formation was found. 1, 14 Also in recent years, variants in the autophagy genes ATG16L1 and IRGM have been linked to CD by genome-wide association scans (GWAS). [15] [16] [17] [18] Autophagy is a fundamental homeostatic cellular process found in all eukaryotic cells. It involves delivery of cytoplasmic components to the lysosome for the degradation within a specific double membrane bound vesicle called the autophagosome. 19 Autophagy can also eliminate intracellular pathogens including viruses, parasites and bacteria and thus plays a role in innate and adaptive immunity, making it an intrinsic part of our immune system. [19] [20] [21] [22] [23] [24] [25] For example, IRGM is necessary for autophagy in human macrophages and has a documented role in the clearance of intracellular Mycobacteria. 21 Also, carriers of a particular single-nucleotide polymorphism in ATG16L1 have an impaired autophagic clearance of Salmonella, while the other functions of autophagy remain intact. 26 Considering the controversial clinical significance of granulomas, we investigated whether their presence, number or distribution in the bowel wall is related to particular phenotypical characteristics of CD patients. We also hypothesized that genetic variants in autophagy genes may lead to impaired processing of intracellular bacterial components, which in turn could lead to granuloma formation in CD patients. We therefore studied variants in autophagy genes for the association with granuloma formation in CD patients who had undergone bowel resection.
Materials and methods

Patients
All CD patients undergoing surgical resections in the University Hospital Gasthuisberg, Leuven, Belgium, in the period between January 1st, 1991 and December 31th, 2007 were included, except if they were operated for perianal disease only. A total of 464 patients were thus selected. All clinical records were reviewed for gender, age at diagnosis, smoking status, localization and behavior of disease, disease duration prior to surgery, indication for surgery, age at operation, and number of surgical interventions (Table 1) . Localization and behavior of disease at the time of surgery were defined according to Montreal classification. 27 For all included patients, DNA as well as tissue blocks from the resection specimens were available. Informed consent was obtained from all patients and the study was approved by the Ethics Committee of the University hospitals Leuven. 
Histology
All the slides from the surgical specimens of all the patients were studied for the presence of epithelioid granulomas by an experienced gastrointestinal (GI) pathologist (GDH). A mean number of 11 slides (standard deviation, SD: 4.1) per sample were reviewed for a specimen length of 31 ± 18 cm. Epithelioid granulomas were defined as well-circumscribed collections of at least five epithelioid cells (histiocytes with ample homogeneous eosinophilic cytoplasm) with or without accompanying multinucleated giant cells. 28 Isolated giant cells, microgranulomas and pericryptal granulomas as well as foreign body granulomas and histiocyte collections bordering ulcer beds were excluded from the analysis. The presence of granulomas in all layers of the bowel wall as well as in the lymph nodes was recorded and the density of granulomas was scored semi-quantitatively as follows: grade 0: no granulomas; grade 1: granulomas in mucosa or submucosa, or up to 10 granulomas present; grade 2: granulomas in all layers of the bowel wall with or without granulomas in the lymph nodes, or more than 10 granulomas present. 1 
Genotyping
DNA was isolated from whole venous blood using a salting out procedure and stored at −80 ºC. 29 A total of 79 SNPs were genotyped. Patients were genotyped for rs2241880 (ATG16L1) using a polymerase chain reaction (PCR) allele resistant mutation system (ARMS) assay; and for rs10065172 (IRGM) using a PCR restriction fragment length polymorphisms (RFLP) method. From a list of 39 known human orthologs of yeast Atg genes, 30 we prioritized 13 genes, based on their position in a known chronic inflammatory bowel diseases (IBD) locus or in a genomic region surrounding a hit from the recent Genome Wide Association Study (GWAS) meta-analysis. 31 For each of the selected genes, including the region up to 10 kB upstream and 5 kB downstream, an optimized set of tagging SNPs was selected using information from the Hap Map Project 32 and the Haploview software (ver. 4.0). Using this approach, 77 SNPs were selected for genotyping (Table 2 ) on the Sequenom® Mass ARRAY platform at our institution.
Statistics
Basic group comparisons were performed using SPSS 15.0 for Windows (SPSS Inc, Chicago, IL) and Haploview 4.1. Differences in continuous variables between granuloma positive and negative patients were tested using the independent sample t-test and the Mann-Whitney U test for normally and not normally distributed variables, respectively.
Allele and genotype frequencies were compared between groups using the χ 2 or Fischer's exact test when appropriate. For each SNP, univariate associations considering the dominant and additive models of inheritance were performed using the statistical software package R (2.9.1). The minor allele was defined as the less frequent allele in the control group.
In a second step, SNPs showing a p b 0.1 for association with granulomas under a dominant model of inheritance in univariate analysis were tested in a multiple logistic regression analysis using a backward stepwise Wald approach. Finally, SNPs and clinical variables associated with granulomas in univariate analysis were tested in a multiple logistic regression analysis using a backward stepwise Wald approach. Significance level was set at 0.05.
Results
Histology
After revision of all the slides, granulomas were present in 75% (348/464) of the cases (35.1% grade 1 and 39.9% grade 2). Granuloma positive and negative patients did not differ significantly with regard to either specimen length, or number of slides investigated (Table 3) . Granulomas were found in the mucosa in 28.73%, submucosa in 72.98%, muscularis propria 54.31% and adventitia/subserosa in 72.70% of granuloma positive cases. Dividing patients in groups based on the localization of the distal margin of the resection specimen (small bowel, right colon, left colon and rectum), we noticed that granuloma frequency increased steadily towards the distal end of the GI tract. The lowest prevalence was found in the small bowel, with granulomas in 72% of specimens, and the highest prevalence was in the rectum, where granulomas were found in 86% of the specimens (Fig. 1 ).
Granulomas and clinical characteristics
Granuloma positive patients were diagnosed with CD at a younger age (p = 0.04), and needed surgery earlier (p = 0.0001), with a shorter disease duration prior to first surgery (p = 0.04) compared with patients without granulomas (Table 3) . Upper GI involvement, ileocolonic and perianal disease were associated with granuloma formation while having exclusively ileal disease seemed protective against granuloma formation ( In the subset of patients who underwent their first surgery for CD in our study period (n = 321), we found a significant difference in the age at surgery, with granuloma positive patients being operated at a younger age in comparison to the granuloma negative group (33. 
Granuloma formation and variants in autophagy genes
All SNPs were in Hardy-Weinberg equilibrium in the control group (data not shown). Overview of the significant findings is given in Table 4 . Whereas no significant association was found between granuloma formation and variants in the ATG16L1 and IRGM genes, we found a modest overrepresentation of the minor allele of rs5973822 (ATG4A) in the granuloma positive patients as compared to the granuloma negative group (p = 0.03, OR 4.13, 95% CI [0.97-17.63]). Due to the fact that ATG4A is located on the X chromosome, analysis of allelic association was performed in the total cohort and in males and females separately. However, although the difference existed in both sexes, significance was reached only when examining the whole cohort.
The major allele of rs17109951 (FNBP1L) was overrepresented in the granuloma positive group (p = 0.02, OR = 1.84, 95% CI [1.07-3.14]. This same SNP was also found associated under both the additive and dominant models of inheritance, where having at least 1 minor allele of this variant is protective for the development of granulomas (p = 0.03, OR = 0.53, 95% CI [0.3-0.83]). Carriers of major allele of rs17109951 (FNBP1L) had a significantly shorter disease duration to surgery (p = 0.03) while homozygous patients Figure 1 Frequency of granulomas going distally in the GI tract.
were both younger at surgery (p = 0.04) and had shorter disease duration to surgery (p = 0.02). In ATG4D, 2 SNPs showed a significant association with granuloma formation: (Table 5) .
Multiple logistic regression analysis including clinical variables, as well as SNPs with p b 0.1 for the association with granulomas under a dominant model of inheritance, indicated that only a single SNP, rs7248036 (ATG4D) conferring a protective effect, remained independently associated with granuloma formation (p = 0.04). Age at surgery, upper GI involvement, presence of perianal disease and smoking remained independently associated with granuloma formation (Table 6 ).
Discussion
Granulomas are a characteristic pathological finding in CD patients but they are found only in a proportion of CD patients.
1-3,5-8 Significant differences exist in proportion of patients with granulomas with regards to the type of sample being studied. Accordingly, granulomas are found in around 45-70% of surgical samples in contrast to 20-40% if endoscopic biopsy samples are studied.
1-3,5-8 Therefore, in order to reliably detect patients with granulomas we searched for granulomas in surgical specimens as opposed to endoscopic biopsies as using biopsy samples carries a risk of a substantial false negative rate. The prevalence of granulomas in our study population was high as granulomas were found in 75% of patients. We believe that this number is representative as our study represents the largest published cohort of surgically treated CD patients and we performed an in-depth analysis of the presence, distribution and density of NS granulomas within the bowel wall. We further found that the frequency of granulomas increased towards the distal GI tract, with the highest frequency in the rectum. This finding is in concordance with other reports in literature. 1, 4 The reason for the higher frequency of granulomas in the distal portions of the GI tract is unclear although the highest concentration of bacteria is also found in the distal part of the colon, suggesting that granuloma formation may represent a defense mechanism.
Looking at the distribution of granulomas across the layers of the bowel wall, we found that only 28.73% had granulomas in the mucosa. This finding emphasizes the importance of examining resection specimens when studying granulomas, as opposed to endoscopic biopsy samples, as this approach will invariably lead to a high false negative rate.
There are conflicting data regarding the clinical significance of granulomas. [2] [3] [4] [5] [6] [7] [8] Several studies have reported associations with a younger age at diagnosis and a more aggressive disease course. [5] [6] [7] Our results are in agreement with these reports and suggest that the presence of granulomas is a marker of a more aggressive clinical phenotype. In our cohort granuloma positive patients were significantly younger at diagnosis, had surgery at a significantly younger age and after a significantly shorter duration of disease. Presence of granulomas was also associated with more extensive involvement of small and large bowel and with perianal disease, while isolated ileal disease was protective for granuloma formation. These findings are most likely the consequence of the higher frequency of granulomas in the distal portions of the GI tract. The association with upper GI involvement is therefore hard to explain but could suggest that patients with granulomas are more likely to have extensive disease as only one of these patients had isolated upper GI involvement.
We also found an association between the granuloma grade and young age at diagnosis and surgery. The highest reported frequency of granulomas in the literature has been in the pediatric population, with 82% of patients having granulomas in resection specimens. 33 The reason why young age predisposes to granuloma formation is unclear, but one could hypothesize that it is due to the more reactive immune system at this age as opposed to older patients where a certain degree of tolerance has developed for luminal antigens. The fact that patients with higher granuloma grade are diagnosed, and undergo surgery, at an earlier age seems to reflect the more pronounced dysregulation of the immune response in this subset of patients, leading to a more robust granuloma formation and a more aggressive disease course.
Epidemiological data have shown that smoking increases the risk of developing CD as well as having a more aggressive disease course, with smokers having more disease flares and higher rates of postoperative recurrence. [34] [35] [36] We observed a significant association between smoking and granuloma formation. It is plausible that this relationship is a consequence of inflammation-promoting effects of smoking with granulomas as a reflection of more severe inflammation in smokers. In any case this association warrants further study.
In this study, we hypothesized that granuloma formation may result from impaired autophagy. This process is likely involved in CD pathogenesis given the identification of ATG16L1 and IRGM as susceptibility genes for the disease. Autophagy plays an important role in innate immunity by controlling the elimination of intracellular pathogens, including viruses, bacteria and parasites. [20] [21] [22] [23] It is also linked to adaptive immune responses as autophagy is responsible for the delivery of cytoplasmic antigens to MHC class II proteins for antigen presentation. 24, 25 We were able to detect an association in four genes, ATG4A, ATG4D, FNBP1L, and ATG2A. In the case of ATG4D and FNBP1L the presence of the variant conferred protection against granuloma formation, whereas the presence of the ATG2A variant represents a risk factor for granuloma formation. ATG4A and ATG4D are one of four human paralogues of the Atg4 gene found in yeast. In yeast, Atg4 is a crucial regulatory component of autophagosome formation involved in the covalent linkage of phosphatidilethanolamine (PE) to Atg8, a step necessary for formation of the autophagosome, and subsequent delipidation of outer membrane-bound PE from Atg8 and PE recycling. 37 It is further known that FNBP1L binds ATG3, and that it is essential for autophagy of Salmonella enterica serovar typhimurium while it is dispensable for other forms of autophagy.
38
ATG2A is a human homologue of Atg2 found in yeasts. In yeast, Atg2 plays a role in trafficking of Atg9, the only integral membrane protein of the autophagosome. However, at present, no knowledge exists regarding the possible functional effects of the observed variants on autophagy function, so one can only hypothesize regarding their effect on granuloma formation. Interestingly, the CDassociated variant in ATG16L1 results in impaired autophagy of Salmonella while other functions of autophagy remain unaffected. 26 This suggests that variants in autophagy genes may specifically involve the immunity-related functions of autophagy, while leaving other functions intact. This could result in an altered efficacy of the autophagic machinery in handling intracellular bacteria, or in an enhanced presentation of cytosolic antigens to MCH class II proteins, leading in both cases to overactivation of the adaptive immune responses and granuloma formation. The fact that some variants act as risk factors whereas others have a protective effect (ATG4D and FNBP1L) on granuloma formation is difficult to explain at this stage. It is possible that, from an evolutionary point of view, it was better to have a more robust autophagy against particular intracellular pathogens, as these were the major causes of disease and death, even at the cost of risking overactivation of the immune system. However, functional data are needed in order to clarify the effects of observed mutations on autophagy function. We detected a significant association between variants in FNBP1L and ATG4D and age at diagnosis, age at surgery and disease duration to surgery. These findings imply that autophagy might also have a disease modifying role in CD. However, these results should be interpreted with caution since the analysis was performed in a cohort of surgically treated CD patients representing only a subset of CD patients with aggressive and complicated disease course. Therefore, these results require confirmation in a cohort of nonoperated CD patients.
Even though we observed modest association with granuloma formation no results remained significant after correction for multiple testing. However, although we studied the largest cohort of surgically treated patients with CD published to date, due to the large number of SNP's tested, our study was still significantly underpowered to detect effects of modest size. Furthermore, due to the fact that we employed a haplotype tagging approach, the observed modest associations do not necessarily represent the causal variant and genotyping of additional SNPs from respective haplotype blocks is needed. In that respect, our results warrant replication in an independent cohort of patients.
Since the start of our study, 2 papers were published also investigating a possible relationship between autophagy genes and granulomas. An Israelian study found no differences in allele frequencies of the ATG4A (autophagy-related 4 homolog A) nor the NCF4 (neutrophil cytosolic factor 4) genes and granuloma formation in 307 CD patients with endoscopic biopsies. Patients with granulomas (n = 85 or 27%) were however also younger at diagnosis than patients without granuloma (mean age 19 vs. 27, respectively, p b 0.0001), and were also more likely to undergo surgery (55.3% vs. 34.8%, respectively, p = 0.002). 39 In a similar study from the Netherlands, variants in ATG16L1 and IRGM were studied in 819 IBD patients. No association between granulomas (again diagnosed in endoscopic biopsies) and these variants was observed, 40 which is in agreement with our findings: no association was found between granuloma formation and variants in ATG16L1 and IRGM in our cohort. We also couldn't detect an association between granuloma formation and the ATG4A variant tested in the Israelian study. We did, however, identify an association with a different variant in the same gene (rs5973822), as a result of employing a haplotype tagging approach as opposed to genotyping selected SNPs as in the 2 previously mentioned studies.
In conclusion, we studied the clinical characteristics and effects of variants in autophagy genes on granuloma formation in a large cohort of surgically treated CD patients. Our results demonstrate that the presence of granulomas is a marker of aggressive disease course. Using a haplotype tagging approach, we detected an association of granuloma formation with the presence of particular variants of the autophagy genes ATG4A, ATG2A, ATG4D and FNBP1L. Our findings therefore suggest that the process of autophagy may contribute to granuloma formation.
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